(Q53596680)

16 May 2018

title

Progressive esophagitis caused by Candida albicans with reduced susceptibility to caspofungin. (English)

1 reference

16 May 2018

1 reference

1 reference

4

David S Perlin

1 reference

16 May 2018

author name string

Christopher D Miller

series ordinal

1

1 reference

16 May 2018

Ben W Lomaestro

series ordinal

2

1 reference

16 May 2018

Steven Park

series ordinal

3

1 reference

16 May 2018

language of work or name

English

0 references

publication date

1 June 2006

1 reference

16 May 2018

published in

Pharmacotherapy

1 reference

16 May 2018

volume

26

1 reference

16 May 2018

issue

6

1 reference

16 May 2018

page(s)

877-880

1 reference

16 May 2018

Caspofungin uptake is mediated by a high-affinity transporter in Candida albicans

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

Randomized, double-blind, multicenter study of caspofungin versus amphotericin B for treatment of oropharyngeal and esophageal candidiases

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

Caspofungin activity against clinical isolates of fluconazole-resistant Candida

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

Guidelines for treatment of candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.26.6.877

21 January 2018

Identifiers

DOI

10.1592/PHCO.26.6.877

1 reference

16 May 2018

1 reference

16 May 2018